Italian startup Aptadir has launched with $1.6M to develop drugs targeting DNA hypermethylation for cancer and genetic ...

Delve into the world of radiopharmaceuticals: explore their mechanisms, promising candidates, and the key players driving ...

Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the ...

Through an alliance announced last July, Pfizer has partnered with venture firm Flagship Pioneering to develop 10 new drug ...

See how KBI Biopharma used advanced mass spectrometry to address a cell culture media issue and prevent a potential ...

Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...

Menopause marks the end of periods and fertility and is regarded as a natural part of aging. Occurring typically between the ages of 45 and 50, this period comes with a host of difficult symptoms due ...

The immunology field has recently become one of the hottest areas in the biopharma industry, attracting a major wave of investment over the past couple of years. In fact, there have already been more ...

Famously known as the powerhouse of the cell, the mitochondria is responsible for generating most of the energy that fuels cellular reactions. That’s why when this organelle does not function properly ...